Third member of U.S. FDA advisory panel resigns over Alzheimer’s drug approval By Reuters
2/2 © Reuters. FILE PHOTO: A sign marks a Biogen facility in Cambridge, Massachusetts, U.S. January 26, 2017. REUTERS/Brian Snyder 2/2 By Julie Steenhuysen and Carl O’Donnell (Reuters) – A third member of a panel […]
